Accueil・Liste d'Actions・Omnicell Inc

Omnicell Inc

Fermé

SecteurSoins de santé

36.89 1.54

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

35.76

Max

37.2

Chiffres clés
By Trading Economics
Revenu	13M 24M
Ventes	2.3M 312M
P/E Moyenne du Secteur	44.482 57.371
BPA	0.7
Marge bénéficiaire	7.78
Employés	3,485
EBITDA	-22M 14M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+52.65% upside

Dividendes
By Acuity
Prochains Résultats	29 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-248M 1.6B
Ouverture précédente	35.35
Clôture précédente	36.89

Sentiment de l'Actualité

By Acuity

97%

2 / 340 Classement par Healthcare

Omnicell Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 août 2026, 22:51 UTC

Omnicell Inc shares are lower in after-market hours, reflecting broader negative sentiment amid rising sovereign bond yields and inflation concerns.

17 août 2026, 23:36 UTC

Omnicell shares are higher in after-market trading, gaining after closing up on Monday. The broader market showed mixed performance amid rising crude oil prices.

14 août 2026, 23:01 UTC

Omnicell Inc shares rose in after-market trading, recovering from an early low. The stock remains below its 20-day moving average.

12 août 2026, 19:41 UTC

News

Omnicell shares are higher amid positive sentiment ahead of management's meetings with KeyBanc in Philadelphia and New York this month.

11 août 2026, 22:16 UTC

Omnicell Inc shares are higher in after-market trading, with no specific news identified. Market focus remains on inflation data and Federal Reserve interest rate hikes.

10 août 2026, 19:16 UTC

News

Omnicell Inc reported second-quarter revenue of $312.21 million and upgraded its guidance, contributing to shares trading higher since Friday's close.

7 août 2026, 23:16 UTC

Omnicell Inc shares are rising in after-market trading, reflecting broader market dynamics following a disappointing jobs report that reduced interest rate hike expectations.

6 août 2026, 23:21 UTC

Omnicell Inc's shares are higher in after-market trading, showing strength following Thursday's close amid broader market dynamics and upcoming economic data.

5 août 2026, 22:02 UTC

Omnicell Inc shares are higher in after-market trading, continuing an earlier session advance. The stock remains below its 20-day moving average and one-month range.

4 août 2026, 20:07 UTC

Omnicell Inc. shares are trading lower, reflecting ongoing weakness and remaining significantly below the 20-day moving average. The stock peaked earlier in the session.

3 août 2026, 23:02 UTC

Omnicell Inc shares are lower in after-market trading, following a weak session and remaining below their 20-day moving average. No specific news was identified.

31 juil. 2026, 22:01 UTC

Omnicell Inc. shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down and remaining below the 20-day moving average.

30 juil. 2026, 23:21 UTC

Omnicell Inc. shares moved lower in after-market trading amid notable volatility and broader market dynamics, including mixed Asian market performance and geopolitical tensions.

29 juil. 2026, 18:26 UTC

News

Omnicell Inc shares are higher as analysts maintain a positive outlook ahead of Thursday's Q2 earnings announcement, following a strong prior quarter with $309.9 million in revenue.

28 juil. 2026, 20:51 UTC

Omnicell Inc shares are lower in after-market hours. The decline comes amid no specific news and follows three sessions of higher closes.

27 juil. 2026, 19:46 UTC

Omnicell Inc shares are higher today, supported by falling crude oil prices and easing geopolitical tensions following U.S. diplomatic efforts with Iran.

24 juil. 2026, 20:13 UTC

Omnicell Inc shares are lower in after-market hours. No specific company news was identified to explain the decline amid recent market volatility.

22 juil. 2026, 18:46 UTC

News

Omnicell Inc is trading lower amid negative sentiment and concerns over financial performance. The stock's current price is $41.95.

21 juil. 2026, 19:51 UTC

Omnicell Inc's shares are lower during Tuesday's session, reversing from a recent trend of higher daily closes. No specific news was identified for the decline.

20 juil. 2026, 19:36 UTC

News

Omnicell Inc shares are lower amid a report suggesting the stock is one to avoid, citing modest revenue growth and declining earnings per share. Current valuation is $45.39.

Comparaison

Variation de prix

Omnicell Inc prévision

Objectif de Prix

By TipRanks

52.65% hausse

Prévisions sur 12 Mois

Moyen 55 USD 52.65%

Haut 65 USD

Bas 45 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

Achat

Maintien

Vente

Basé sur 6 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

2 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.